{"content":"<li class=\"n-box-item date-title\" data-end=\"1508817599\" data-start=\"1508731200\" data-txt=\"Monday, December 23, 2019\">Monday, October 23, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3303148\" data-ts=\"1508803211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303148-lions-gate-picks-indian-media-vet-jain-to-lead-mumbai-office\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lions Gate picks Indian media vet Jain to lead Mumbai office</a></h4><ul>   <li>Lions Gate Entertainment (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='red'>-1.7%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='red'>-2%</font>) has named Indian media veteran Rohit Jain to <a href=\"https://seekingalpha.com/pr/16976800-lionsgate-appoints-leading-media-executive-rohit-jain-managing-director-head-new-office-india\" target=\"_blank\">lead its new office in Mumbai</a>.</li>    <li>Jain has spent the past seven years as deputy CEO of Videocon d2h (<a href=\"http://seekingalpha.com/symbol/VDTH\" target=\"_blank\">VDTH</a> <font color='red'>-2.7%</font>), which he helped lead to a Nasdaq listing in 2015 (and a merger with Dish TV India last year).</li>    <li>Prior to that he worked in stints at Aon, PricewaterhouseCoopers and Deloitte.</li>    <li>India has achieved double-digit annual growth across television, film, interactive games and delivery of content to digital platforms, the company notes.</li>    <li>The company's Mumbai office will spearhead all licensing to loal platforms from films, TV series and library content under Lionsgate and Starz brands.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='green'>+1.4%</font>; <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> flat.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303148\" data-linked=\"Lions Gate picks Indian media vet Jain to lead Mumbai office\" data-tweet=\"$LGF.A $LGF.A $LGF.B - Lions Gate picks Indian media vet Jain to lead Mumbai office https://seekingalpha.com/news/3303148-lions-gate-picks-indian-media-vet-jain-to-lead-mumbai-office?source=tweet\" data-url=\"https://seekingalpha.com/news/3303148-lions-gate-picks-indian-media-vet-jain-to-lead-mumbai-office\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303147\" data-ts=\"1508802721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303147-lumentum-jumps-amid-strong-forecast-from-austrias-ams\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumentum jumps amid strong forecast from Austria&#39;s AMS</a></h4><ul>   <li>A strong move up today for Lumentum (<a href=\"http://seekingalpha.com/symbol/LITE\" target=\"_blank\">LITE</a> <font color='green'>+6.3%</font>) may be tied to a strong forecast from Austria-based AMS, Bloomberg notes.</li>    <li>Loup Ventures analyst Austin Bohlig says AMS is believed to have a manufacturing relationship with Lumentum for 3-D sensor modules, and a strong AMS forecast is a \"great sign\" for Lumentum, he tells Bloomberg.</li>    <li>AMS said it expected \"very strong quarter-on-quarter growth\" as optical solution ramps in its consumer business continued at high volumes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303147\" data-linked=\"Lumentum jumps amid strong forecast from Austria&#39;s AMS\" data-tweet=\"$LITE - Lumentum jumps amid strong forecast from Austria&#39;s AMS https://seekingalpha.com/news/3303147-lumentum-jumps-amid-strong-forecast-from-austrias-ams?source=tweet\" data-url=\"https://seekingalpha.com/news/3303147-lumentum-jumps-amid-strong-forecast-from-austrias-ams\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303146\" data-ts=\"1508802395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FWONA\" target=\"_blank\">FWONA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303146-formula-one-considers-cutting-friday-practices-to-save\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Formula One considers cutting Friday practices to save</a></h4><ul>   <li>Auto-racing group Formula One (<a href=\"http://seekingalpha.com/symbol/FWONA\" target=\"_blank\">FWONA</a> <font color='red'>-3.2%</font>) is considering <a href=\"https://www.forbes.com/sites/csylt/2017/10/23/exclusive-f1-considering-cancelling-friday-practice-sessions/\" target=\"_blank\">canceling the practices it holds on Fridays</a> before race weekends as a cost-saving measure that would allow teams to compete in more races.</li>    <li>The practice is considered a fan favorite as it sells discounted tickets to those who can't afford the race-day price tag, and allows the organization to test development drivers.</li>    <li>With the return of the French Grand Prix, the number of races it's putting on next year will tie a record of 21.</li>    <li>While Formula One's contract allows for up to 25 races a year, three teams hold a sort of veto if there are more than 20 events in a season, or if it exceeds 17 with events outside Europe, the U.S. or Canada exceeds 60% of the total.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303146\" data-linked=\"Formula One considers cutting Friday practices to save\" data-tweet=\"$FWONA $FWONB $FWONK - Formula One considers cutting Friday practices to save https://seekingalpha.com/news/3303146-formula-one-considers-cutting-friday-practices-to-save?source=tweet\" data-url=\"https://seekingalpha.com/news/3303146-formula-one-considers-cutting-friday-practices-to-save\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303139\" data-ts=\"1508799460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303139-videogame-sales-ride-destiny-2-to-39-surge-in-september\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Videogame sales ride &#39;Destiny 2&#39; to 39% surge in September</a></h4><ul>   <li>Videogame sales surged in September, with Activision Blizzard's (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='red'>-1.9%</font>) <i>Destiny 2</i> providing a huge lift and broad gains recorded across categories.</li>    <li>Overall sales were up 39% Y/Y, according to NPD Group, totaling $1.21B. Hardware sales were up 34% to $316M, software rose 49% (console/portable rose 52% to $726M, and PC game software was down 20% to $18M), and accessory sales were up 9% to $150M.</li>    <li><i>Destiny 2</i> drove more launch-month consumer spend than any other release this year. \"With one month of sales, <i>Destiny 2</i> also becomes the best-selling game of 2017 year to date, and the third best-selling game of the 12-month rolling period ending September 2017, trailing only <i>Call of Duty: Infinite Warfare</i> and <i>Battlefield 1,\"</i> says NPD's Mat Piscatella.</li>    <li>Just behind <em>Destiny 2</em> on the dollar-sales chart is the month's top-selling sports game, <i>NBA 2K18</i> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='green'>+0.1%</font>), which also rode one month to be the year's best-selling sports game. Rounding out the September top 10: No. 3, <i>Madden NFL 18</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>); No. 4, <i>FIFA 18</i> (<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>); No. 5, <i>Mario &amp; Rabbids: Kingdom Battle</i> (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='red'>-0.4%</font>); No. 6, <i>Marvel vs. Capcom: Infinite</i> (<a href=\"http://seekingalpha.com/symbol/CCOEY\" target=\"_blank\">CCOEY</a> <font color='red'>-1.2%</font>); No. 7, <i>Grand Theft Auto V</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>); No. 8, <i>NHL 18</i> (<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>); No. 9, <i>The Legend of Zelda: Breath of the Wild</i> (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='green'>+0.4%</font>); No. 10,<i> Tom Clancy's Rainbox Six: Siege</i> (<a href='https://seekingalpha.com/symbol/UBSFY' title='UbiSoft Entertainment Inc. ADR'>OTCPK:UBSFY</a>).</li>    <li>PlayStation 4 (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-0.1%</font>) led platforms in overall consumer spend, while Nintendo Switch sold the most units among this generation of consoles, and Nintendo's retro-styled SNES Classic Edition was the overall top-selling hardware unit in September. PS4 remains the YTD hardware leader.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='green'>+0.6%</font>; <a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color='green'>+0.1%</font>; <a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a> <font color='green'>+0.1%</font>.</li>      <li>ETF: <a href='https://seekingalpha.com/symbol/GAMR' title='PureFunds Video Game Tech ETF'>GAMR</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3303139\" data-linked=\"Videogame sales ride &#39;Destiny 2&#39; to 39% surge in September\" data-tweet=\"$EA $EA $TTWO - Videogame sales ride &#39;Destiny 2&#39; to 39% surge in September https://seekingalpha.com/news/3303139-videogame-sales-ride-destiny-2-to-39-surge-in-september?source=tweet\" data-url=\"https://seekingalpha.com/news/3303139-videogame-sales-ride-destiny-2-to-39-surge-in-september\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303134\" data-ts=\"1508795500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRX\" target=\"_blank\">AMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303134-impax-labsplus-4-fda-approves-generic-renvela\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impax Labs +4% as FDA approves generic Renvela</a></h4><ul>     <li>Impax Laboratories (IPXL) <font color='green'>+3.9%</font> after-hours on news that the <a href=\"https://seekingalpha.com/pr/16976601-impax-announces-fda-approval-launch-generic-renvela-sevelamer-carbonate-tablets-800-mg\" target=\"_blank\">FDA approved</a> its generic version of Sanofi's (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) Renvela sevelamer carbonate tablets.</li><li>IPXL says it has immediately started commercialization of the product; sales of Renvela are reflected in the company's previously issued FY 2017 EPS guidance of $0.55-$0.70.</li>     <li>U.S. sales of sevelamer carbonate tablets totaled $1.9B for the 12 months ending August 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303134\" data-linked=\"Impax Labs +4% as FDA approves generic Renvela\" data-tweet=\"$AMRX $AMRX $SNY - Impax Labs +4% as FDA approves generic Renvela https://seekingalpha.com/news/3303134-impax-labsplus-4-fda-approves-generic-renvela?source=tweet\" data-url=\"https://seekingalpha.com/news/3303134-impax-labsplus-4-fda-approves-generic-renvela\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303125\" data-ts=\"1508794697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303125-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/KNL' title='Knoll, Inc.'>KNL</a> <font color='green'>+11.7%</font>. <a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/CYD' title='China Yuchai International Limited'>CYD</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+1.1%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-17.9%</font>. <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-16.1%</font>. <a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-6.5%</font>. <a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='red'>-4.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303125\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$KNL $DBVT $SNEC - After Hours Gainers / Losers https://seekingalpha.com/news/3303125-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3303125-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303113\" data-ts=\"1508792203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRC\" target=\"_blank\">FRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303113-first-republic-down-1_4-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Republic down 1.4% on capital raise</a></h4><ul><li>The company is selling 2M shares in a secondary offering. The underwriters have a greenshoe option for another 300K shares.</li><li><a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a>&nbsp;<font color='red'>-1.4%</font>&nbsp;after hours</li><li>Source: <a href=\"https://seekingalpha.com/pr/16976689-first-republic-bank-announces-common-stock-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303113\" data-linked=\"First Republic down 1.4% on capital raise\" data-tweet=\"$FRC - First Republic down 1.4% on capital raise https://seekingalpha.com/news/3303113-first-republic-down-1_4-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3303113-first-republic-down-1_4-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303101\" data-ts=\"1508791299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPN\" target=\"_blank\">SPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303101-superior-energy-misses-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Superior Energy misses by $0.01, misses on revenue</a></h4><ul><li>Superior Energy (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>): Q3 EPS of -$0.33 <font color='red'>misses by $0.01</font>.</li><li>Revenue of $506M (+55.1% Y/Y) <font color='red'>misses by $4.97M</font>.</li><li>Shares <font color='green'>+1.3%</font>.</li><li><a href='https://seekingalpha.com/pr/16976720-superior-energy-services-announces-third-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303101\" data-linked=\"Superior Energy misses by $0.01, misses on revenue\" data-tweet=\"$SPN - Superior Energy misses by $0.01, misses on revenue https://seekingalpha.com/news/3303101-superior-energy-misses-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303101-superior-energy-misses-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303098\" data-ts=\"1508791159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303098-whirlpool-slumps-after-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool slumps after guidance cut</a></h4><ul> <li>Whirlpool (NYSE:<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>) slumps after lowering full-year guidance on the heels of a Q3 profit shortfall.</li> <li>The company now expects FY17 EPS of $13.60 to $13.90 vs. $14.50 to $15.00 prior and $14.62 consensus.</li> <li>Whirlpool management says margins are under pressure due to ongoing raw material inflation and an unfavorable product sales mix.  Global cost-based prices increases are being pushed to Whirlpool customers in Q4 and Q1 of 2018.</li> <li>\"We reaffirm our 2020 goals and are confident that our existing and newly-announced actions will put us firmly back on track to deliver our commitments,\" notes Whirlpool CFO Jim Peter.</li> <li>WHR <font color='red'>-7.39%</font> AH to $169.02.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303098\" data-linked=\"Whirlpool slumps after guidance cut\" data-tweet=\"$WHR - Whirlpool slumps after guidance cut https://seekingalpha.com/news/3303098-whirlpool-slumps-after-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3303098-whirlpool-slumps-after-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303096\" data-ts=\"1508791037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMBS\" target=\"_blank\">RMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303096-rambus-beats-q3-guidance-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rambus beats Q3, guidance estimates</a></h4><ul><li>        Rambus (NASDAQ:<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus, Inc.'>RMBS</a>) shares are&nbsp;<font color='red'>down 0.07%</font>&nbsp;aftermarket following Q3 results with EPS and revenue beats.</li><li>                  Q4 outlook: revenue, $98M to $104M (consensus: $100.54M); total operating costs and expenses, $64M to $69M; operating income, $29M to $40M; EPS, $0.16 to $0.22 (consensus: $0.17).    </li><li>               Financials: Total operating costs and expenses totaled $82.1M, up $4M on last year&rsquo;s quarter, with R&amp;D spending up nearly $3M on the year to $36.2M and SG&amp;A up $2M to $26.8M. Operating margin was 17% compared to 13% last year. Rambus ended the quarter with $182M in cash and equivalents.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303061-rambus-beats-0_02-beats-revenue\" target=\"_blank\">Rambus beats by $0.02, beats on revenue</a> (Oct. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303096\" data-linked=\"Rambus beats Q3, guidance estimates\" data-tweet=\"$RMBS - Rambus beats Q3, guidance estimates https://seekingalpha.com/news/3303096-rambus-beats-q3-guidance-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3303096-rambus-beats-q3-guidance-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303090\" data-ts=\"1508790825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303090-intercepts-oca-shows-treatment-effect-in-mid-stage-psc-study-shares-ahead-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept&#39;s OCA shows treatment effect in mid-stage PSC study; shares ahead 3% after hours</a></h4><ul><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) is up&nbsp;<font color='green'>3%</font>&nbsp;after hours on modest volume in response to its <a href=\"https://seekingalpha.com/pr/16976609-intercept-announces-positive-results-phase-2-aesop-trial-evaluating-oca-treatment-patients\" target=\"_blank\">announcement </a>of positive results from a Phase 2 clinical trial, AESOP, evaluating obeticholic acid &#40;OCA&#41; for the treatment of primary sclerosing cholangitis &#40;PSC&#41;. The data were presented at The Liver Meeting in Washington, D.C.</li><li>Patients receiving 5 mg OCA per day (with the option of increasing the dose to 10 mg per day) experienced a statistically significant reduction on alkaline phosphatase &#40;ALP&#41; versus placebo at week 24, the primary endpoint. ALP is a liver enzyme biomarker for liver damage (if elevated).</li><li>A two-year open-label extension study is ongoing. There are no currently approved therapies for PSC, a rare chronic liver disease characterized by the progressive destruction of bile ducts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303090\" data-linked=\"Intercept&#39;s OCA shows treatment effect in mid-stage PSC study; shares ahead 3% after hours\" data-tweet=\"$ICPT - Intercept&#39;s OCA shows treatment effect in mid-stage PSC study; shares ahead 3% after hours https://seekingalpha.com/news/3303090-intercepts-oca-shows-treatment-effect-in-mid-stage-psc-study-shares-ahead-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3303090-intercepts-oca-shows-treatment-effect-in-mid-stage-psc-study-shares-ahead-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303062\" data-ts=\"1508789221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303062-corbus-pharma-readies-stock-offering-shares-down-23-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus Pharma readies stock offering; shares down 23% after hours</a></h4><ul><li>Corbus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) slumps&nbsp;<font color='red'>23%</font>&nbsp;after hours in response to its <a href=\"https://seekingalpha.com/pr/16976597-corbus-pharmaceuticals-holdings-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned public offering</a> of common stock. Price, volume and terns have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303062\" data-linked=\"Corbus Pharma readies stock offering; shares down 23% after hours\" data-tweet=\"$CRBP - Corbus Pharma readies stock offering; shares down 23% after hours https://seekingalpha.com/news/3303062-corbus-pharma-readies-stock-offering-shares-down-23-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3303062-corbus-pharma-readies-stock-offering-shares-down-23-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303061\" data-ts=\"1508789158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMBS\" target=\"_blank\">RMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303061-rambus-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rambus beats by $0.02, beats on revenue</a></h4><ul><li>Rambus (NASDAQ:<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus, Inc.'>RMBS</a>): Q3 EPS of $0.19 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $99.1M (+10.3% Y/Y) <font color='green'>beats by $0.14M</font>.</li><li>Shares <font color='green'>+3.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16976621-rambus-reports-third-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3303061\" data-linked=\"Rambus beats by $0.02, beats on revenue\" data-tweet=\"$RMBS - Rambus beats by $0.02, beats on revenue https://seekingalpha.com/news/3303061-rambus-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303061-rambus-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303053\" data-ts=\"1508788512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303053-ad-revenues-increase-for-nfl-broadcasts-despite-flagging-viewership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad revenues increase for NFL broadcasts despite flagging viewership</a></h4><ul>   <li>Ad revenue for NFL broadcasts <a href=\"http://www.broadcastingcable.com/despite-ratings-issues-nfl-ad-revenues-september/169565\" target=\"_blank\">continues to hold up</a>, defying lower expectations caused by a decline in viewership for the football games.</li>    <li>Standard Media Index estimates that in-game ad revenues were up 2% in September, to $513M. That's despite leaguewide ratings down about 5% Y/Y.</li>    <li>What's at play? According to SMI, more ads per game (about a 2% higher commercial load); make-good ads, which are up in NFL games; and rising unit prices (about 7% higher across networks for 30-second spots).</li>    <li>The average 30-second spot is $515,000; on NBC (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-1.9%</font>), <i>Sunday Night Football</i> spots are up to $717,100 from $705,000; Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-3.2%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-3%</font>) spots are up to $553,000 from $550,400; CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-1.6%</font>) spots are up to $496,400 from $438,900. Meanwhile rates are down a bit on cable: ESPN's (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.7%</font>) are down to $304,700, from a year-ago $316,600 (though revenues were higher as it added spots to offset the price decrease).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303053\" data-linked=\"Ad revenues increase for NFL broadcasts despite flagging viewership\" data-tweet=\"$FOX $FOX $FOXA - Ad revenues increase for NFL broadcasts despite flagging viewership https://seekingalpha.com/news/3303053-ad-revenues-increase-for-nfl-broadcasts-despite-flagging-viewership?source=tweet\" data-url=\"https://seekingalpha.com/news/3303053-ad-revenues-increase-for-nfl-broadcasts-despite-flagging-viewership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303050\" data-ts=\"1508787739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303050-cleveland-cliffs-downgraded-j-p-morgan-on-lower-u-s-iron-ore-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs downgraded at J.P. Morgan on lower U.S. iron ore pricing</a></h4><ul>     <li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-2.6%</font>) is lower after J.P. Morgan <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+Cliffs+Natural+Resources+%28CLF%29+to+Neutral+on+Valuation/13410720.html\" target=\"_blank\">downgrades</a> shares to Neutral from Overweight with a $7 price target, cut from $9.50, to reflect the firm's lower estimates for U.S. iron ore realized pricing due to anticipated headwinds in Q4.</li>     <li>JPM analyst Michael Gambardella still expects CLF to generate $190M in cash flow during 2017, up from $138M in 2018, which will help fund its hot briquetted iron plant.</li>     <li>CLF currently is in talks with potential partners for the HBI project, which Gambardella thinks could be more than one equity partner with CLF maintaining a majority interest.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303050\" data-linked=\"Cleveland-Cliffs downgraded at J.P. Morgan on lower U.S. iron ore pricing\" data-tweet=\"$CLF - Cleveland-Cliffs downgraded at J.P. Morgan on lower U.S. iron ore pricing https://seekingalpha.com/news/3303050-cleveland-cliffs-downgraded-j-p-morgan-on-lower-u-s-iron-ore-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3303050-cleveland-cliffs-downgraded-j-p-morgan-on-lower-u-s-iron-ore-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303047\" data-ts=\"1508787221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVO\" target=\"_blank\">VIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303047-meridians-magellan-unit-slapped-fda-warning-letter-related-to-lead-testing-gear-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meridian&#39;s Magellan unit slapped with FDA Warning Letter related to lead testing gear; shares down 4%</a></h4><ul><li>Meridian Biosciences (<a href='https://seekingalpha.com/symbol/VIVO' title='Meridian Bioscience Inc.'>VIVO</a> <font color='red'>-3.9%</font>) is down on almost 80% higher volume in reaction to the <a href=\"https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2017/ucm581591.htm\" target=\"_blank\">FDA Warning Letter </a>received by its Magellan Diagnostics unit related to its LeadCare, LeadCare II, LeadCare Ultra and LeadCare Plus Blood Lead Testing Systems.</li><li>The <a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm581683.htm\" target=\"_blank\">deficiencies</a>, recording during an on-site inspection and review of follow-up documents, are many, including distributing unapproved products (LeadCare II and LeadCare Ultra), failure to submit marketing applications for device, protocol and labeling changes and failure to adhere to good manufacturing practice standards.</li><li>The company must take prompt action to address the deficiencies or face possible FDA action that could include injunction, seizure or civil monetary penalties.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3278519-meridian-unit-magellan-hot-water-fda-lead-test-results\" target=\"_blank\">Meridian unit Magellan in hot water with FDA over lead test results</a> (July 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303047\" data-linked=\"Meridian&#39;s Magellan unit slapped with FDA Warning Letter related to lead testing gear; shares down 4%\" data-tweet=\"$VIVO - Meridian&#39;s Magellan unit slapped with FDA Warning Letter related to lead testing gear; shares down 4% https://seekingalpha.com/news/3303047-meridians-magellan-unit-slapped-fda-warning-letter-related-to-lead-testing-gear-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3303047-meridians-magellan-unit-slapped-fda-warning-letter-related-to-lead-testing-gear-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303041\" data-ts=\"1508785939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DYNT\" target=\"_blank\">DYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303041-dynatronics-secures-u-s-distribution-rights-to-three-zimmer-medizinsysteme-devices-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynatronics secures U.S. distribution rights to three Zimmer MedizinSysteme devices; shares ahead 22%</a></h4><ul><li>Thinly traded nano cap Dynatronics (<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='green'>+22.2%</font>) heads north on a healthy 36x surge in volume, albeit on turnover of only 358K shares, in response to its <a href=\"https://seekingalpha.com/pr/16976100-dynatronics-announces-strategic-alliance-partnership-zimmer-medizinsysteme\" target=\"_blank\">distribution deal</a> with Zimmer MedizinSysteme GmbH.</li><li>Under the terms of the agreement, Dynatronics will be the exclusive U.S. distributor of Zimmer's <a href=\"https://zimmer.de/en/products/physical-therapy/diathermy-therapy/thermo-pro/\" target=\"_blank\">ThermoPro </a>(shortwave diathermy), <a href=\"https://zimmer.de/en/products/physical-therapy/shockwave-therapy/enpuls-version-2-0/\" target=\"_blank\">enPuls </a>(radial pulse therapy) and <a href=\"https://zimmer.de/en/products/physical-therapy/laser-therapy/opton-pro/\" target=\"_blank\">OptonPro</a> (class IV laser).</li><li>The company has been distributing the products on an non-exclusive basis for the last nine months. It says the market opportunity for the Zimmer devices is over $100M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303041\" data-linked=\"Dynatronics secures U.S. distribution rights to three Zimmer MedizinSysteme devices; shares ahead 22%\" data-tweet=\"$DYNT - Dynatronics secures U.S. distribution rights to three Zimmer MedizinSysteme devices; shares ahead 22% https://seekingalpha.com/news/3303041-dynatronics-secures-u-s-distribution-rights-to-three-zimmer-medizinsysteme-devices-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3303041-dynatronics-secures-u-s-distribution-rights-to-three-zimmer-medizinsysteme-devices-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303037\" data-ts=\"1508785062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303037-norways-1t-wealth-fund-watchdog-reviewing-energy-transfer-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Norway&#39;s $1T wealth fund watchdog reviewing Energy Transfer investment</a></h4><ul>     <li>The ethics watchdog for Norway&rsquo;s $1T sovereign wealth fund - the world's largest - is <a href=\"http://www.reuters.com/article/us-northdakota-pipeline-norway-swf/norway-wealth-fund-watchdog-reviewing-investment-in-u-s-pipeline-firm-idUSKBN1CS1HH\" target=\"_blank\">reviewing allegations</a> that Energy Transfer Partners (ETP <font color='red'>-1.8%</font>) may breach the fund&rsquo;s investment guidelines.</li>     <li>Under rules set by Norway&rsquo;s parliament, the fund's investments must meet guidelines related to the environment, human rights, governance and other issues.</li>     <li>The Council on Ethics reportedly has met Native American opponents of the Dakota Access pipeline to discuss related concerns on two occasions, most recently on Oct. 3 in Oslo.</li>     <li>The fund held $248M of ETP corporate bonds at the end of 2016, according to the latest available data.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303037\" data-linked=\"Norway&#39;s $1T wealth fund watchdog reviewing Energy Transfer investment\" data-tweet=\"$ET - Norway&#39;s $1T wealth fund watchdog reviewing Energy Transfer investment https://seekingalpha.com/news/3303037-norways-1t-wealth-fund-watchdog-reviewing-energy-transfer-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3303037-norways-1t-wealth-fund-watchdog-reviewing-energy-transfer-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303036\" data-ts=\"1508785053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQIX\" target=\"_blank\">EQIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303036-equinix-significantly-expands-access-to-oracle-cloud-infrastructure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinix significantly expands access to Oracle Cloud Infrastructure</a></h4><ul>   <li>Equinix (<a href=\"http://seekingalpha.com/symbol/EQIX\" target=\"_blank\">EQIX</a> <font color='red'>-1.7%</font>) is adding direct access to the Oracle Cloud Infrastructure in 16 more of its markets</a>.</li>    <li>The company is adding OCI direct access in several of its International Business Exchange centers in North America and Europe.</li>    <li>Part of the move is bringing OCI FastConnect to its FR5 IBX data center in Frankfurt, and allowing connecting to OCI FastConnect via Equinix Cloud Exchange in 15 other metros (eight in North America, seven in Europe).</li>    <li>That brings Equinix's FastConnect deployment to six in total, and 18 metros where connectivity to FastConnect is available.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303036\" data-linked=\"Equinix significantly expands access to Oracle Cloud Infrastructure\" data-tweet=\"$EQIX - Equinix significantly expands access to Oracle Cloud Infrastructure https://seekingalpha.com/news/3303036-equinix-significantly-expands-access-to-oracle-cloud-infrastructure?source=tweet\" data-url=\"https://seekingalpha.com/news/3303036-equinix-significantly-expands-access-to-oracle-cloud-infrastructure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303035\" data-ts=\"1508785050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303035-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TISA' title='Top Image Systems, Ltd.'>TISA</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303035\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$VERI $SOL $STX - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3303035-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303035-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303032\" data-ts=\"1508784849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DYNT\" target=\"_blank\">DYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303032-dynatronics-announces-strategic-alliance-partnership-stockplus-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynatronics announces strategic alliance partnership; Stock +17%</a></h4><ul>     <li>Dynatronics Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a>) announced that it has signed an exclusive distribution agreement for the United States with Zimmer MedizinSysteme GmbH for select therapy equipment.</li>     <li>Dynatronics has been operating as a distributor for Zimmer for the last 9 months on a non-exclusive basis, building its base of experience and confidence in the products during that period.</li>     <li>Under the terms of the agreement, DYNT will be the exclusive U.S. distributor for Zimmer's ThermoProTM (Shortwave Diathermy), enPulsTM (Radial Pulse Therapy), and OptonProTM (Class IV Laser) products.  Combining Dynatronics' existing modalities with these Zimmer products will provide Dynatronics customers in the U.S. with a complete range of modality products.</li>     <li>Currently, Dynatronics sales account for less than 2% of the relevant U.S. market opportunity for these products, which is estimated to be over $100M.</li><li>Shares&nbsp;<font color='green'>+17%</font></li><li><a href=\"https://seekingalpha.com/pr/16976100-dynatronics-announces-strategic-alliance-partnership-zimmer-medizinsysteme\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3303032\" data-linked=\"Dynatronics announces strategic alliance partnership; Stock +17%\" data-tweet=\"$DYNT - Dynatronics announces strategic alliance partnership; Stock +17% https://seekingalpha.com/news/3303032-dynatronics-announces-strategic-alliance-partnership-stockplus-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3303032-dynatronics-announces-strategic-alliance-partnership-stockplus-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303031\" data-ts=\"1508784784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303031-reuters-lam-cfo-says-no-big-acquisition-attempts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Lam CFO says no more big acquisition attempts</a></h4><ul><li>        Lam Research&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) CFO tells <a href=\"https://www.reuters.com/article/us-broadsoft-m-a-cisco-systems/cisco-buys-broadsoft-for-1-71-bln-in-software-push-idUSKBN1CS02Q\" target=\"_blank\">Reuters</a> that last year&rsquo;s failed bid for KLA-Tencor marks the end of major acquisition efforts for the company.</li><li>               Doug Bettinger says Lam will still consider smaller deals but that &ldquo;large scale M&amp;A is perhaps behind us.&rdquo;&nbsp;</li><li>               Bettinger cites Applied Materials&rsquo; $10B bid for Tokyo Electron that regulators blocked in 2015 as a sign the tech manufacturing market can&rsquo;t accommodate large mergers or acquisitions at this time.&nbsp;&nbsp;</li><li>               The CFO also says that Lam will likely top its $1B R&amp;D spending last year during FY18.&nbsp;</li><li>               Lam Research shares are&nbsp;<font color='green'>up 0.99%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301650-lam-research-reports-q4-guidance-beats-shipments-dropped-6-percent\" target=\"_blank\">Lam Research reports Q4, guidance beats but Shipments dropped 6%</a> (Oct. 17)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302648-taiwan-semiconductor-orders-69_43m-equipment\" target=\"_blank\">Taiwan Semiconductor orders $69.43M in equipment</a> (Oct. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303031\" data-linked=\"Reuters: Lam CFO says no more big acquisition attempts\" data-tweet=\"$LRCX - Reuters: Lam CFO says no more big acquisition attempts https://seekingalpha.com/news/3303031-reuters-lam-cfo-says-no-big-acquisition-attempts?source=tweet\" data-url=\"https://seekingalpha.com/news/3303031-reuters-lam-cfo-says-no-big-acquisition-attempts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303030\" data-ts=\"1508784640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303030-financials-top-5-gainers-losers-of-2-50-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 2:50 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CVLY' title='Codorus Valley Bancorp, Inc'>CVLY</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303030\" data-linked=\"Financials - Top 5 Gainers / Losers as of 2:50 PM\" data-tweet=\"$GROW $IRS $BMA - Financials - Top 5 Gainers / Losers as of 2:50 PM https://seekingalpha.com/news/3303030-financials-top-5-gainers-losers-of-2-50-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303030-financials-top-5-gainers-losers-of-2-50-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303029\" data-ts=\"1508784558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRC\" target=\"_blank\">RRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303029-range-resources-cut-j-p-morgan-on-valuation-vs-gas-producing-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Range Resources cut at J.P. Morgan on valuation vs. gas producing peers</a></h4><ul>     <li>Range Resources (<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='red'>-1.9%</font>) is <a href=\"http://www.barrons.com/articles/natural-gas-dont-put-range-resources-on-back-burner-1508769417\" target=\"_blank\">downgraded</a> to Neutral from Overweight with a $22 price target, trimmed from $25, at J.P. Morgan, citing valuation and potential downside risk to the company's 2018 production.</li>     <li>Based on its updated estimates, JPM says RRC trades at 7.2x its 2018 EBITDAX estimate vs. the average valuation of 5.9x for the peer group of gas producers, and trades at 6.9x its 2019 EBITDAX estimate vs. 5.4x for the peer group.\"</li>     <li>Despite the premium valuation, JPM sees lower growth of 10% vs. the peer group median of 15% in 2019 and says its Neutral rating is justified as its stock is trading at a discount to forecast net asset value.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303029\" data-linked=\"Range Resources cut at J.P. Morgan on valuation vs. gas producing peers\" data-tweet=\"$RRC - Range Resources cut at J.P. Morgan on valuation vs. gas producing peers https://seekingalpha.com/news/3303029-range-resources-cut-j-p-morgan-on-valuation-vs-gas-producing-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3303029-range-resources-cut-j-p-morgan-on-valuation-vs-gas-producing-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303027\" data-ts=\"1508784047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVI\" target=\"_blank\">NAVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303027-senator-warren-requests-sec-investigation-navient-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senator Warren requests SEC investigation into Navient trading</a></h4><ul><li>        Senator Elizabeth Warren <a href=\"http://www.reuters.com/article/us-usa-sec-navient/warren-seeks-sec-probe-of-trading-in-shares-of-loan-servicer-navient-idUSKBN1CS2GB\" target=\"_blank\">asks the SEC</a> to investigate the insider trader accusations against Navient (NASDAQ:<a href='https://seekingalpha.com/symbol/NAVI' title='Navient Corp'>NAVI</a>).</li><li>               Warren wrote a letter to the SEC regarding three large trades that happened hours before a congressional committee went public with news that benefitted Navient.&nbsp;</li><li>               The committee revealed the Consumer Financial Protection Bureau, Navient&rsquo;s foe, was losing access to government-provided information needed to continue the fight.&nbsp;</li><li>Navient shares are&nbsp;<font color='red'>down 0.89%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299575-navient-plunges-subprime-loan-lawsuit-update\" target=\"_blank\">Navient plunges after subprime loan lawsuit (update)</a> (Oct. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300173-bloomberg-afl-cio-accuses-navient-inside-trading\" target=\"_blank\">Bloomberg: AFL-CIO accuses Navient of inside trading</a> (Oct. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303027\" data-linked=\"Senator Warren requests SEC investigation into Navient trading\" data-tweet=\"$NAVI - Senator Warren requests SEC investigation into Navient trading https://seekingalpha.com/news/3303027-senator-warren-requests-sec-investigation-navient-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/3303027-senator-warren-requests-sec-investigation-navient-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303024\" data-ts=\"1508783499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UA\" target=\"_blank\">UA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303024-under-armour-may-cut-tennis-and-fishing-from-lineup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour may cut tennis and fishing from its lineup</a></h4><ul>     <li>Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) is considering <a href=\"https://www.wsj.com/articles/under-armour-co-founder-kip-fulks-takes-sabbatical-1508780413\" target=\"_blank\">exiting</a> its tennis and other outdoor categories, according to <i>The Wall Street Journal</i>.</li>     <li>At a retail conference last month, CEO Kevin Armour admitted that the apparel company \"just can't do everything.\"</li>     <li>Sources also tell the WSJ that Under Armour co-founder Kip Fulks is taking a sabbatical from the company. Some of Fulk's duties are already being handled by operating hire Patrik Frisk.</li>     <li>UA <font color='red'>-3.71%</font>. UAA <font color='red'>-3.26%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303024\" data-linked=\"Under Armour may cut tennis and fishing from its lineup\" data-tweet=\"$UA $UA $UAA - Under Armour may cut tennis and fishing from its lineup https://seekingalpha.com/news/3303024-under-armour-may-cut-tennis-and-fishing-from-lineup?source=tweet\" data-url=\"https://seekingalpha.com/news/3303024-under-armour-may-cut-tennis-and-fishing-from-lineup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303023\" data-ts=\"1508783386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303023-halliburtonminus-2-after-warning-of-slower-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton -2% after warning of slower growth</a></h4><ul>     <li>Halliburton (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-2.3%</font>) has turned sharply lower despite a <a href=\"https://seekingalpha.com/news/3302887-halliburton-plus-1-percent-q3-shows-strong-north-america-activity\" target=\"_blank\">solid Q3 earnings</a> report, after <a href=\"http://www.reuters.com/article/us-halliburton-results/halliburton-warns-of-slower-growth-as-u-s-rig-count-drops-idUSKBN1CS1CI?il=0\" target=\"_blank\">warning of slower growth</a> at its oil well drilling and evaluation business.</li>     <li>HAL's Q4 North American revenue from its drilling and evaluation business will fall alongside the average U.S. rig count, CFO Christopher Weber said on this morning's <a href=\"https://seekingalpha.com/article/4115505-halliburtons-hal-ceo-jeff-miller-q3-2017-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>.</li>     <li>HAL;s \"commentary about rig counts driving near term growth creates some level of uncertainty regarding whether they will be able to meet Q4 estimates,&rdquo; says Edward Jones analyst Brian Youngberg.</li>     <li>Wells Fargo also notes that Wall Street <a href=\"http://www.barrons.com/articles/working-the-oil-patch-aint-easy-just-ask-halliburton-1508775480\" target=\"_blank\">expected a stronger Q3 beat</a> in the completion and production business, which has driven recent strong relative performance the firm says the miss raises the bar for future margin growth in order to achieve '\"normalized\" North America margin expectations approaching 20%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303023\" data-linked=\"Halliburton -2% after warning of slower growth\" data-tweet=\"$HAL - Halliburton -2% after warning of slower growth https://seekingalpha.com/news/3303023-halliburtonminus-2-after-warning-of-slower-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3303023-halliburtonminus-2-after-warning-of-slower-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302883\" data-ts=\"1508783277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302883-seagate-reports-q1-beats-sharesplus-8-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seagate reports Q1 beats; shares +8% (update)</a></h4><ul><li>Seagate Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>) shares are&nbsp;<font color='green'>up 8.04%&nbsp;</font>premarket after reporting Q1 results with EPS and revenue beats.</li><li>Key metrics: Gross margin was 29%. Cash flow from operations totaled $237M. Seagate returned $350M through dividends and share repurchases. Cash and equivalents were $2.3B at the end of the quarter.</li><li>Operating expenses totaled $2.4B with the majority coming from cost of revenue. Product development costs were down on the year from $315M to $263M and marketing and administrative costs fell $10M to $145M.</li><li>Will update with Q2 guidance.</li><li><a href=\"https://seekingalpha.com/pr/16975798-seagate-technology-reports-fiscal-first-quarter-2018-financial-results\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3302868-seagate-technology-beats-0_11-beats-revenue\" target=\"_blank\">Seagate Technology beats by $0.11, beats on revenue</a> (Oct. 23)</li><li>Update with Q2 guidance:</li><li>Cash flow from operations expected to total at least two times the Q1 total.</li><li>Revenue expected up 3% to 5% from the September quarter, which would put the range between $2.69B and $2.77B compared to the $2.63B consensus.</li><li>Seagate puts the gross margin forecast between 29% and 33% and says non-GAAP operating expenses will drop 2% to 3% sequentially.</li><li>Conference call <a href=\"https://seekingalpha.com/article/4115460-seagate-technologys-stx-q1-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>.</li><li>Seagate shares are now&nbsp;<font color='green'>up 12.25%</font>.</li><li>Along for the ride are memory stocks (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color='green'>+2.2%</font>) and (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+0.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3302883\" data-linked=\"Seagate reports Q1 beats; shares +8% (update)\" data-tweet=\"$STX $STX $WDC - Seagate reports Q1 beats; shares +8% (update) https://seekingalpha.com/news/3302883-seagate-reports-q1-beats-sharesplus-8-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3302883-seagate-reports-q1-beats-sharesplus-8-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303022\" data-ts=\"1508783092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGO\" target=\"_blank\">AGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303022-assured-guaranty-leads-monolines-lower-on-cautious-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assured Guaranty leads monolines lower on cautious report</a></h4><ul><li>Recent events could challenge Assured Guaranty's (<a href='https://seekingalpha.com/symbol/AGO' title='Assured Guaranty Ltd.'>AGO</a> <font color='red'>-2.6%</font>) business in unexpected ways, says Off Wall Street in a note published today. No other details are available, but one might think the hurricane and Puerto Rico, though that this would affect AGO in an unexpected way is a bit of a head-scratcher.</li><li>Source: Bloomberg's Drew Singer</li><li>MBIA (<a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='red'>-3%</font>), Ambac (<a href='https://seekingalpha.com/symbol/AMBC' title='Ambac Financial'>AMBC</a> <font color='red'>-2.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303022\" data-linked=\"Assured Guaranty leads monolines lower on cautious report\" data-tweet=\"$AGO $AGO $MBI - Assured Guaranty leads monolines lower on cautious report https://seekingalpha.com/news/3303022-assured-guaranty-leads-monolines-lower-on-cautious-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3303022-assured-guaranty-leads-monolines-lower-on-cautious-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303015\" data-ts=\"1508781670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303015-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+96%</font>. <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NDRO-OLD' title='Enduro Royalty Trust'>NDRO-OLD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GEOS' title='Geospace Technologies Corporation'>GEOS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/WG' title='Willbros Group, Inc.'>WG</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303015\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$SNES $CHNR $TUSK - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3303015-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303015-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303014\" data-ts=\"1508781659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303014-william-blair-ringcentral-ok-despite-ciscos-broadsoft-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">William Blair: RingCentral OK despite Cisco&#39;s BroadSoft move</a></h4><ul>   <li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) is <font color='red'>down 2%</font> in the wake of Cisco's (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color='green'>+0.9%</font>) <a href=\"https://seekingalpha.com/news/3302889-cisco-will-acquire-broadsoft-1_9b-cash\" target=\"_blank\">deal to buy BroadSoft</a> (<a href=\"http://seekingalpha.com/symbol/BSFT\" target=\"_blank\">BSFT</a> <font color='green'>+1.6%</font>) for $1.9B, leaving one less buyer for its services -- but William Blair is arguing that RingCentral itself could be an acquisition target.</li>    <li>The firm reiterates its Outperform rating, and notes <a href=\"http://www.barrons.com/articles/ringcentral-can-be-a-buyout-in-wake-of-cisco-broadsoft-says-william-blair-1508777287\" target=\"_blank\">valuation is just 5.4 times estimated revenue</a> for next year -- cheaper than a median multiple for Software-as-a-Service firms of 8.2 times.</li>    <li>Cisco's seen little traction with developers for the Tropo products it's acquired, analyst Bhavan Suri says, and while BroadSoft would strengthens its UCaaS offerings, the combo won't have much impact on RingCentral: \"BroadSoft is often resold by larger telcos, which should leave the competitive landscape unchanged, in our opinion. While Cisco may use BroadSoft to move down market, we ultimately believe the hosted model will be unsuccessful as a result of a lack of innovation and flexibility.\"</li>    <li>Others in the space: <a href='https://seekingalpha.com/symbol/MITL' title='Mitel Networks Corporation'>MITL</a> <font color='green'>+1.8%</font>, <a href='https://seekingalpha.com/symbol/EGHT' title='8X8 Inc'>EGHT</a> <font color='green'>+0.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303014\" data-linked=\"William Blair: RingCentral OK despite Cisco&#39;s BroadSoft move\" data-tweet=\"$RNG $RNG $MITL - William Blair: RingCentral OK despite Cisco&#39;s BroadSoft move https://seekingalpha.com/news/3303014-william-blair-ringcentral-ok-despite-ciscos-broadsoft-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3303014-william-blair-ringcentral-ok-despite-ciscos-broadsoft-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303013\" data-ts=\"1508780940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303013-mannkind-restructures-debt-afrezza-marketing-application-filed-in-brazil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind restructures debt, Afrezza marketing application filed in Brazil</a></h4><ul><li>MannKind (<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-2.9%</font>) announces two developments in its ongoing efforts to shore up its business:</li><li>It has <a href=\"https://seekingalpha.com/pr/16975803-mannkind-restructures-near-term-debt-obligations\" target=\"_blank\">restructured </a>certain outstanding debt, exchanging $27.7M of senior convertible notes due August 2018 for $23.7M of senior convertible notes due October 2021 and 973,236 shares of common stock.</li><li>It has also extended the maturity of $10M of the Deerfield facility from October 31 to January 15, 2018 and allowed the principal, and certain additional outstanding principal, to be converted into common stock.</li><li>The company's partner in Brazil, BIOMM SA, has <a href=\"https://seekingalpha.com/pr/16975640-mannkind-biomm-submit-registration-dossier-brazilian-health-regulatory-agency-anvisa\" target=\"_blank\">filed </a>a registration dossier with regulator ANVISA seeking approval of Afrezza there.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303013\" data-linked=\"MannKind restructures debt, Afrezza marketing application filed in Brazil\" data-tweet=\"$MNKD - MannKind restructures debt, Afrezza marketing application filed in Brazil https://seekingalpha.com/news/3303013-mannkind-restructures-debt-afrezza-marketing-application-filed-in-brazil?source=tweet\" data-url=\"https://seekingalpha.com/news/3303013-mannkind-restructures-debt-afrezza-marketing-application-filed-in-brazil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303009\" data-ts=\"1508779469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303009-foot-locker-bounces-off-multi-year-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foot Locker bounces off multi-year low</a></h4><ul> <li>Buckingham Research <a href=\"https://twitter.com/BuckResearch/status/922422640173899777\" target=\"_blank\">downgrades</a> Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='green'>+1.2%</font>) to a Neutral rating after having the retailer set at Buy.</li> <li>Though the firm thinks Foot Locker is a long-term winner in retail, the major catalysts to drive earnings growth aren't seen arriving until the back half of 2018.</li> <li>The Buckingham price target on Foot Locker is slashed to $29.</li> <li>Shares of Foot Locker hit a multi-year low of $30.40 earlier before recovering nicely.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303009\" data-linked=\"Foot Locker bounces off multi-year low\" data-tweet=\"$FL - Foot Locker bounces off multi-year low https://seekingalpha.com/news/3303009-foot-locker-bounces-off-multi-year-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3303009-foot-locker-bounces-off-multi-year-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303008\" data-ts=\"1508779396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303008-caesars-entertainment-gains-after-barrons-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Entertainment gains after Barron&#39;s nod</a></h4><ul> <li>Shares of Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a>) are <font color='green'>up 2.46%</font> on volume 2X normal activity after the casino stock is mentioned favorably in <a href=\"http://www.barrons.com/articles/caesars-returns-to-building-its-gaming-empire-1508558364?mod=hp_highlight_6&amp;\" target=\"_blank\">Barron's</a>.</li> <li>\"Caesars has a quality, value-creating management team and several factors that could push the stock higher in the next two years,\" Incline Global Management's Jeff Lignelli tells the publication.</li> <li>The company's high rate of renovation in Las Vegas and the licensing potential of its loyalty programs are seen as earnings drivers.</li> <li>After taking a pause on M&amp;A due to the extended bankruptcy road, Caesars is finally in a position to make some moves with $2B in cash.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3303008\" data-linked=\"Caesars Entertainment gains after Barron&#39;s nod\" data-tweet=\"$CZR - Caesars Entertainment gains after Barron&#39;s nod https://seekingalpha.com/news/3303008-caesars-entertainment-gains-after-barrons-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3303008-caesars-entertainment-gains-after-barrons-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303007\" data-ts=\"1508779126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303007-google-investigating-pixel-2-xl-screen-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google investigating Pixel 2 XL screen issue</a></h4><ul><li>        Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) is &ldquo;actively investigating&rdquo; reports of burn-in on the POLED screens of some Pixel 2 XL screens, according to a statement to <a href=\"https://www.theverge.com/2017/10/22/16518298/google-investigating-pixel-2-xl-screen-burn-in\" target=\"_blank\">The Verge</a>. &nbsp;</li><li>           Burn-in refers to when a certain part of the interface, for example, the navigation bar, discolors so that the part shows up regardless of what the user is doing. </li><li> Burn-in isn&rsquo;t uncommon but it usually takes months to years before it happens not the week for the Pixel 2 XL, which has also experienced display issues related to low lighting. </li><li> In better news, the problem could be an image retention problem known as ghosting instead of actual burn-in. Ghosting isn&rsquo;t permanent. </li><li> The AMOLED screen on the Pixel 2 appears unaffected. </li><li> Alphabet shares are&nbsp;<font color='red'>down 1.29%</font>&nbsp;for Class C&nbsp;and&nbsp;<font color='red'>down 1.37%</font>&nbsp;for Class A.&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3299597-youtubes-search-update-targets-fake-news-pixel-2-comes-added-benefits\" target=\"_blank\">YouTube's search update targets fake news; Pixel 2 comes with added benefits</a> (Oct. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303007\" data-linked=\"Google investigating Pixel 2 XL screen issue\" data-tweet=\"$GOOG $GOOG $GOOGL - Google investigating Pixel 2 XL screen issue https://seekingalpha.com/news/3303007-google-investigating-pixel-2-xl-screen-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3303007-google-investigating-pixel-2-xl-screen-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303150\" data-ts=\"1508778557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TERP\" target=\"_blank\">TERP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303150-terraform-power-upgraded-baird-brookfiled-provides-growth-engine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TerraForm Power upgraded at Baird, as Brookfiled provides growth engine</a></h4><ul>     <li>TerraForm Power (<a href='https://seekingalpha.com/symbol/TERP' title='TerraForm Power, Inc.'>TERP</a> <font color='green'>+2.7%</font>) is <a href=\"https://www.streetinsider.com/Analyst+Comments/Baird+Upgrades+TerraForm+Power+%28TERP%29+to+Outperform/13410857.html\" target=\"_blank\">upgraded</a> to Outperform from Neutral with a $19 price target, up from $13, at Baird, which sees the sponsorship from Brookfield Asset Management providing a potential engine to restore growth.</li>     <li>Baird also believes TERP is an effective way to invest in secular growth in renewables, and thinks TERP's targeted distribution compound annual growth rate should reward investors over the intermediate term.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303150\" data-linked=\"TerraForm Power upgraded at Baird, as Brookfiled provides growth engine\" data-tweet=\"$TERP - TerraForm Power upgraded at Baird, as Brookfiled provides growth engine https://seekingalpha.com/news/3303150-terraform-power-upgraded-baird-brookfiled-provides-growth-engine?source=tweet\" data-url=\"https://seekingalpha.com/news/3303150-terraform-power-upgraded-baird-brookfiled-provides-growth-engine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303004\" data-ts=\"1508778160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303004-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CVLY' title='Codorus Valley Bancorp, Inc'>CVLY</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3303004\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$CCCR-OLD $IRS $GROW - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3303004-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3303004-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303001\" data-ts=\"1508778022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCLI\" target=\"_blank\">BCLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303001-brainstorm-nabs-new-patent-covering-nurown-shares-ahead-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BrainStorm nabs new patent covering NurOwn; shares ahead 4%</a></h4><ul><li>BrainStorm Cell Therapeutics (<a href='https://seekingalpha.com/symbol/BCLI' title='BrainStorm Cell Therapeutics Inc.'>BCLI</a> <font color='green'>+4.2%</font>) has <a href=\"https://seekingalpha.com/pr/16976144-brainstorm-expands-patent-portfolio-include-new-us-patent-nurown-technology-parkinsons\" target=\"_blank\">received </a>a Notice of Allowance from the USPTO covering methods of treating amyotrophic lateral sclerosis &#40;ALS&#41; and Parkinson's disease using mesenchymal stem cells (NurOwn) that secrete neurotrophic factors.</li><li>CEO Chaim Lebovits says, \"We continue to protect our technology through strategic intellectual property achievements and this Notice of Allowance from the USPTO is a welcome addition to our IP portfolio.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3303001\" data-linked=\"BrainStorm nabs new patent covering NurOwn; shares ahead 4%\" data-tweet=\"$BCLI - BrainStorm nabs new patent covering NurOwn; shares ahead 4% https://seekingalpha.com/news/3303001-brainstorm-nabs-new-patent-covering-nurown-shares-ahead-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3303001-brainstorm-nabs-new-patent-covering-nurown-shares-ahead-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3303000\" data-ts=\"1508777576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3303000-citigroup-upgrades-science-applications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup upgrades Science Applications</a></h4><ul><li>        Citigroup <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171023065943SAIC\" target=\"_blank\">upgrades</a> Science Applications (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>) to Buy from Neutral.</li><li>               Science Applications shares are&nbsp;<font color='green'>up 1.48%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298620-saic-announces-consolidations-turnaround-efforts\" target=\"_blank\">SAIC announces consolidations in turnaround efforts</a> (Oct. 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299394-science-applications-declares-0_31-dividend\" target=\"_blank\">Science Applications declares $0.31 dividend</a> (Oct. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3303000\" data-linked=\"Citigroup upgrades Science Applications\" data-tweet=\"$SAIC - Citigroup upgrades Science Applications https://seekingalpha.com/news/3303000-citigroup-upgrades-science-applications?source=tweet\" data-url=\"https://seekingalpha.com/news/3303000-citigroup-upgrades-science-applications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302999\" data-ts=\"1508777411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AJRD\" target=\"_blank\">AJRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302999-aerojet-rocketdyneminus-5-jefferies-downgrades-to-hold-from-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aerojet Rocketdyne -5% as Jefferies downgrades to Hold from Buy</a></h4><ul>     <li>Aerojet Rocketdyne (<a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc'>AJRD</a> <font color='red'>-5.5%</font>) sinks after Jefferies <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10211443/cool-your-jets-aerojet-downgraded-after-59-run-since-ma\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $35 price target, following the stock's 59% run-up since the end of Q1.</li>     <li>Jefferies says the market has reset expectations for 2018, given H1's 13% revenue growth, but believes the new year may present some challenges, with the loss of a key program and more modest revenues for the Space Launch Systems program, which could contribute $260M to 2017 revenues but decline next year as the launch vehicle approaches first launch in 2019.</li>     <li>The firm also notes revenues from ULA have been rising even as the number of space launches has declined, but it expects volumes to decline 2018; it also believes Wall Street expectations do not account for the SLS program and ULA revenue headwinds of $120M and $140M, respectively, for 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302999\" data-linked=\"Aerojet Rocketdyne -5% as Jefferies downgrades to Hold from Buy\" data-tweet=\"$AJRD - Aerojet Rocketdyne -5% as Jefferies downgrades to Hold from Buy https://seekingalpha.com/news/3302999-aerojet-rocketdyneminus-5-jefferies-downgrades-to-hold-from-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3302999-aerojet-rocketdyneminus-5-jefferies-downgrades-to-hold-from-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302998\" data-ts=\"1508777214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KALV\" target=\"_blank\">KALV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302998-kalvista-pharma-regains-momentum-from-merck-stoked-spike-shares-ahead-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KalVista Pharma regains momentum from Merck-stoked spike, shares ahead 22%</a></h4><ul><li>Thinly traded micro cap KalVista Pharmaceuticals (<a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color='green'>+21.5%</font>) is up on more than a 5x surge in volume as shares regain upward momentum from its October 10 announcement of a DME collaboration with Merck.</li><li>Shares more than doubled on the news but couldn't hold onto most of the gain, ending up ~39% for the day.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300131-kalvista-pharma-inks-deal-merck-dme-candidate-kvd001-shares-108-percent-premarket\" target=\"_blank\">KalVista Pharma inks deal with Merck for DME candidate KVD001; shares up 108% premarket</a> (Oct. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302998\" data-linked=\"KalVista Pharma regains momentum from Merck-stoked spike, shares ahead 22%\" data-tweet=\"$KALV - KalVista Pharma regains momentum from Merck-stoked spike, shares ahead 22% https://seekingalpha.com/news/3302998-kalvista-pharma-regains-momentum-from-merck-stoked-spike-shares-ahead-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3302998-kalvista-pharma-regains-momentum-from-merck-stoked-spike-shares-ahead-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302996\" data-ts=\"1508776862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302996-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+92%</font>. <a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/EXAC' title='Exactech, Inc.'>EXAC</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='red'>-46%</font>. <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TISA' title='Top Image Systems, Ltd.'>TISA</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302996\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SNES $AIMT $EXAC - Midday Gainers / Losers https://seekingalpha.com/news/3302996-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3302996-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302989\" data-ts=\"1508776017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUB\" target=\"_blank\">CUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302989-cubicplus-3-nyc-chooses-electronic-fare-collection-system-for-transit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cubic +3% as NYC chooses electronic fare collection system for transit</a></h4><ul>     <li>Military training and transport specialist Cubic Corp. (<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color='green'>+3.1%</font>) is higher after reportedly topping five other bids to <a href=\"https://www.nytimes.com/2017/10/23/nyregion/metrocard-subway-new-york.html\" target=\"_blank\">win a proposed deal</a> to run a new electronic fare collection system for New  York City's transit system.</li>     <li>A committee of the Metropolitan Transportation Authority is expected to approve a $573M contract to install new electronic readers in 500 subway turnstiles and on 600 buses in NYC beginning late next year, reaching the rest of the city&rsquo;s subway stations and buses by late 2020.</li>     <li>CUB previously designed a similar system in London and is bidding for new systems in Boston, San Francisco and Brisbane, which together with NYC offers an opportunity the company says worth as much as $4B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302989\" data-linked=\"Cubic +3% as NYC chooses electronic fare collection system for transit\" data-tweet=\"$CUB - Cubic +3% as NYC chooses electronic fare collection system for transit https://seekingalpha.com/news/3302989-cubicplus-3-nyc-chooses-electronic-fare-collection-system-for-transit?source=tweet\" data-url=\"https://seekingalpha.com/news/3302989-cubicplus-3-nyc-chooses-electronic-fare-collection-system-for-transit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302986\" data-ts=\"1508775734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIGR\" target=\"_blank\">EIGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302986-eiger-bios-hdv-pegylated-interferon-lambda-shows-positive-effect-in-mid-stage-hepatitis-d\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eiger Bio&#39;s HDV pegylated interferon lambda shows positive effect in mid-stage hepatitis D study; shares down 6% on reports of jaundice</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16975714-eiger-announces-positive-phase-2-interim-24-week-data-pegylated-interferon-lambda-hepatitis\" target=\"_blank\">Preliminary&nbsp;Results</a> from a Phase 2 clinical trial, LIMT HDV, evaluating Eiger BioPharmaceuticals' (<a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a> <font color='red'>-5.5%</font>) pegylated interferon lambda (Lambda) as monotherapy in patients with hepatitis delta virus &#40;HDV&#41; infection showed a positive treatment effect. The data were presented at The Liver Meeting in Washington, D.C.</li><li>The 33-subject open-label study assessed two doses of Lambda (120 or 180 micrograms) administered via subcutaneous injection every week for 48 weeks.</li><li>About 30% (n=10/33) reached 24 weeks of treatment at data cutoff. 40% (n=4/10) had undetectable HDV by week 24 as measured by PCR. Half (n=5/10) achieved at least a 2 log decline (99% decline) in HDV RNA by week 24.</li><li>Lambda was well-tolerated in the majority of patients through week 24, although there were apparently three cases of jaundice, probably the reason for the downward pressure.</li><li>The company acquired global rights to Orphan Drug- and Fast Track-tagged Lambda from Bristol-Myers Squibb in April 2016.</li><li>HDV is thought to affect up to 20M people worldwide. It is present in ~4 - 6% of HBV carriers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302986\" data-linked=\"Eiger Bio&#39;s HDV pegylated interferon lambda shows positive effect in mid-stage hepatitis D study; shares down 6% on reports of jaundice\" data-tweet=\"$EIGR - Eiger Bio&#39;s HDV pegylated interferon lambda shows positive effect in mid-stage hepatitis D study; shares down 6% on reports of jaundice https://seekingalpha.com/news/3302986-eiger-bios-hdv-pegylated-interferon-lambda-shows-positive-effect-in-mid-stage-hepatitis-d?source=tweet\" data-url=\"https://seekingalpha.com/news/3302986-eiger-bios-hdv-pegylated-interferon-lambda-shows-positive-effect-in-mid-stage-hepatitis-d\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302983\" data-ts=\"1508774637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302983-seagate-announces-long-term-agreement-toshiba-memory-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seagate announces long-term agreement with Toshiba memory unit</a></h4><ul><li>Seagate Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>) has entered into a long-term supply agreement with Toshiba&rsquo;s (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) memory chip business, according to CEO Dave Mosley during the post-earnings analyst call.</li><li>Mosley says the agreement could &ldquo;increase the potential for meaningful future revenue growth&rdquo; from Seagate&rsquo;s NAND portfolio and expand its product line.</li><li>Seagate will release more details closer to the deal&rsquo;s closing.</li><li>Seagate shares are&nbsp;<font color='green'>up 12.16%.</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3302883-seagate-reports-q1-beats-shares-plus-8-percent\" target=\"_blank\">Seagate reports Q1 beats; shares +8%</a> (Oct. 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301009-toshiba-wants-mend-fences-western-digital-fab-6-investment\" target=\"_blank\">Toshiba wants to mend fences with Western Digital on Fab 6 investment</a> (Oct. 13)</li><li>Update: Read the call transcript <a href=\"https://seekingalpha.com/article/4115460-seagate-technologys-stx-q1-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">here</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302983\" data-linked=\"Seagate announces long-term agreement with Toshiba memory unit\" data-tweet=\"$STX $STX $TOSBF - Seagate announces long-term agreement with Toshiba memory unit https://seekingalpha.com/news/3302983-seagate-announces-long-term-agreement-toshiba-memory-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3302983-seagate-announces-long-term-agreement-toshiba-memory-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302981\" data-ts=\"1508774484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302981-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NC' title='NACCO Industries Inc.'>NC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302981\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$NC $VFC $FTFT - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3302981-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302981-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302978\" data-ts=\"1508774188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGO\" target=\"_blank\">EGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302978-eldorado-goldminus-26-after-cutting-production-guidance-kisladag-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold -26% after cutting production guidance at Kisladag mine</a></h4><ul>     <li>Eldorado Gold (<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-26%</font>) plunges after <a href=\"https://seekingalpha.com/pr/16975568-eldorado-gold-provides-update-kisladag-operations\" target=\"_blank\">cutting guidance</a> for gold production from its flagship Kisladag mine in Turkey, saying recovery from the leach pad at the operation has lagged internal expectations.</li>     <li>Eldorado says it now expects 2017 production from Kisladag of 170K-180K oz., down from a June estimate of 180K-210K oz. and the company's original 2017 guidance for 230K-245K oz.</li>     <li>Citing the production shortfall and reduced mine life for Kisladag, Credit Suisse <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Credit+Suisse+Downgrades+Eldorado+Gold+Corp+%28EGO%29+to+Underperform/13412947.html\" target=\"_blank\">downgrades</a> EGO to Underperform from Neutral and slashes its stock price target to $1.50 from $2.40.</li>     <li>CS analyst Anita Soni says arbitration issues in Greece and $600M in debt repayment due in 2020 could pressure the company&rsquo;s outlook even further.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302978\" data-linked=\"Eldorado Gold -26% after cutting production guidance at Kisladag mine\" data-tweet=\"$EGO - Eldorado Gold -26% after cutting production guidance at Kisladag mine https://seekingalpha.com/news/3302978-eldorado-goldminus-26-after-cutting-production-guidance-kisladag-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3302978-eldorado-goldminus-26-after-cutting-production-guidance-kisladag-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302972\" data-ts=\"1508772894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302972-seven-stars-cloudplus-6-on-red-coin-licensing-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seven Stars Cloud +6% on Red Coin licensing deal</a></h4><ul>   <li>Seven Stars Cloud (NASDAQ:<a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>) is <font color='green'>up 6%</font> after announcing it's reached a <a href=\"https://seekingalpha.com/pr/16976110-seven-stars-cloud-announces-technology-licensing-agreement-red-coin-chain-securitization\" target=\"_blank\">licensing deal</a> for its Red Coin Chain joint venture.</li>    <li>Guangxi Dragon Coin will get a nonexclusive license to use Red Coin's platform exclusively for real estate-based securitization.</li>    <li>In return, SSC gets 17.9% of the equity of Courage Investment Group, the parent of Guangxi Dragon Coin -- a stake valued at about HK$151M (about $19.35M).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302972\" data-linked=\"Seven Stars Cloud +6% on Red Coin licensing deal\" data-tweet=\"$SSC-OLD - Seven Stars Cloud +6% on Red Coin licensing deal https://seekingalpha.com/news/3302972-seven-stars-cloudplus-6-on-red-coin-licensing-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3302972-seven-stars-cloudplus-6-on-red-coin-licensing-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302971\" data-ts=\"1508772848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLX\" target=\"_blank\">HLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302971-helix-energyminus-10-after-completing-strategic-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helix Energy -10% after completing strategic review</a></h4><ul>     <li>Helix Energy (<a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a> <font color='red'>-10.2%</font>) falls as much as 13% after the company says in its earnings conference call that it recently finished a strategic review but will focus on strengthening its balance sheet, executing operationally and expanding profit margins.</li>     <li><a href=\"https://seekingalpha.com/news/3300016-wsj-helix-energy-exploring-options-shares-jump-7-percent\" target=\"_blank\">Two weeks ago</a>, <em>WSJ</em> reported that HLX was exploring alternatives including a potential sale of the company.</li>     <li>Shares already were lower after reporting in-line <a href=\"https://seekingalpha.com/news/3302792-helix-energy-solutions-eps-line-misses-revenue\" target=\"_blank\">Q3 earnings</a> and forecasting FY 2017 revenues of $570M-$590M vs. $583M analyst consensus estimate.</li><li>Source:&nbsp;Briefing.com</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302971\" data-linked=\"Helix Energy -10% after completing strategic review\" data-tweet=\"$HLX - Helix Energy -10% after completing strategic review https://seekingalpha.com/news/3302971-helix-energyminus-10-after-completing-strategic-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3302971-helix-energyminus-10-after-completing-strategic-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302970\" data-ts=\"1508772516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302970-general-electric-tumbles-5-after-downgrades-baml-is-buyer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Electric tumbles 5% after downgrades, but BAML is a buyer</a></h4><ul><li>General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) managed a strong bounce into positive territory on Friday following a big earnings miss and guidance cut. Shares are back in major retreat this morning though,&nbsp;<font color='red'>down 4.75%</font>&nbsp;after a <a href=\"https://seekingalpha.com/news/3302820-ge-moves-lower-downgrades\" target=\"_blank\">couple of downgrades</a> and price target cuts.</li><li>Bank of America's Andrew Obin, however, <a href=\"https://www.cnbc.com/2017/10/23/ge-drops-again-as-wall-street-battles-over-what-to-do-with-the-blue-chip.html\" target=\"_blank\">upgrades to Buy from Neutral</a>, with $27 price target suggesting nearly&nbsp;<font color='green'>20% upside</font>.</li><li>Obin: \"Our key assumption is that new Power outlook is conservative enough where it does not need to be revised down again.\" Earnings revisions, he says, have been the key driver for GE's stock price over the past ten years, and \"negative revisions are bottoming.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3302970\" data-linked=\"General Electric tumbles 5% after downgrades, but BAML is a buyer\" data-tweet=\"$GE - General Electric tumbles 5% after downgrades, but BAML is a buyer https://seekingalpha.com/news/3302970-general-electric-tumbles-5-after-downgrades-baml-is-buyer?source=tweet\" data-url=\"https://seekingalpha.com/news/3302970-general-electric-tumbles-5-after-downgrades-baml-is-buyer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302965\" data-ts=\"1508771716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNXR\" target=\"_blank\">CNXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302965-connecture-to-delist-from-nasdaq-global-market-shares-down-46\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Connecture to delist from Nasdaq Global Market, shares down 46%</a></h4><ul><li>Thinly traded nano cap Connecture (<a href='https://seekingalpha.com/symbol/CNXR' title='Connecture'>OTC:CNXR</a> <font color='red'>-45.7%</font>) has <a href=\"https://seekingalpha.com/pr/16975282-connecture-inc-announces-intention-voluntarily-delist-nasdaq-global-market-list-otcqx-market\" target=\"_blank\">announced </a>that it will voluntarily delist from the Nasdaq Global Market on or about November 9 due to its inability to meet certain listing requirements. The company says it expects shares to trade on the OTCQX thereafter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302965\" data-linked=\"Connecture to delist from Nasdaq Global Market, shares down 46%\" data-tweet=\"$CNXR - Connecture to delist from Nasdaq Global Market, shares down 46% https://seekingalpha.com/news/3302965-connecture-to-delist-from-nasdaq-global-market-shares-down-46?source=tweet\" data-url=\"https://seekingalpha.com/news/3302965-connecture-to-delist-from-nasdaq-global-market-shares-down-46\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302963\" data-ts=\"1508771386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QDEL\" target=\"_blank\">QDEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302963-fda-clears-quidels-sofia-lyme-test-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Quidel&#39;s Sofia Lyme test; shares up 1%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16975884-quidel-receives-fda-clearance-point-care-sofia-lyme-fia\" target=\"_blank\">grants 510(k) clearance</a> for Quidel's (<a href='https://seekingalpha.com/symbol/QDEL' title='Quidel Corporation'>QDEL</a> <font color='green'>+1.1%</font>) Sofia Lyme FIA test. The company says it can rapidly differentiate between human IgM and IgG antibodies to <em>Borrelia burgdorferi</em> in serum or plasma samples. The test is performed the company's <a href=\"https://www.quidel.com/immunoassays/sofia-tests-kits\" target=\"_blank\">Sofia </a>fluorescent immunoassay analyzer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302963\" data-linked=\"FDA clears Quidel&#39;s Sofia Lyme test; shares up 1%\" data-tweet=\"$QDEL - FDA clears Quidel&#39;s Sofia Lyme test; shares up 1% https://seekingalpha.com/news/3302963-fda-clears-quidels-sofia-lyme-test-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3302963-fda-clears-quidels-sofia-lyme-test-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302960\" data-ts=\"1508770958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAC\" target=\"_blank\">EXAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302960-exactech-to-merge-tpg-capital-in-go-private-deal-shares-up-31\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exactech to merge with TPG Capital in go-private deal; shares up 31%</a></h4><ul><li>Thinly traded Exactech (<a href='https://seekingalpha.com/symbol/EXAC' title='Exactech, Inc.'>EXAC</a> <font color='green'>+30.9%</font>) is up on a 50x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16975834-exactech-enters-definitive-agreement-tpg-capital-go-private\" target=\"_blank\">announcement </a>that will merge with TPG Capital in a go-private transaction at $42 per share.</li><li>The deal should close next quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302960\" data-linked=\"Exactech to merge with TPG Capital in go-private deal; shares up 31%\" data-tweet=\"$EXAC - Exactech to merge with TPG Capital in go-private deal; shares up 31% https://seekingalpha.com/news/3302960-exactech-to-merge-tpg-capital-in-go-private-deal-shares-up-31?source=tweet\" data-url=\"https://seekingalpha.com/news/3302960-exactech-to-merge-tpg-capital-in-go-private-deal-shares-up-31\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302937\" data-ts=\"1508770839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302937-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EXAC' title='Exactech, Inc.'>EXAC</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='red'>-46%</font>. <a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a> <font color='red'>-9%</font>. ADHD <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302937\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$EXAC $AIMT $PETS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3302937-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3302937-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302959\" data-ts=\"1508770688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STT\" target=\"_blank\">STT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302959-state-street-down-3-despite-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">State Street down more than 3% despite earnings beat</a></h4><ul><li>Q3 EPS operating earnings of $648M or $1.71 per share compared to $532M and $1.35 a year ago, and topped estimates by $0.09 per share.</li><li>Net interest income of $645M up 20.1% Y/Y. Fee revenue of $2,321B up 4.9%. Expenses of $1.988B up 4.1%.</li><li>Maybe of concern to the bulls were servicing fees up just 3.7% Y/Y to $1.351B.</li><li>Assets under custody of $32.1T up 10% Y/Y. AUM of $2.673T up 9.3%.</li><li>Net long-term institutional flows, however, were a negative $39B for the quarter, and a negative $87B YTD.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302823-state-street-beats-0_09-beats-revenue\" target=\"_blank\">State Street beats by $0.09, beats on revenue</a> (Oct. 23)</li><li><a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>&nbsp;<font color='red'>-3.35%</font>&nbsp;for the session, but still&nbsp;<font color='green'>up more than 20%</font>&nbsp;for the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302959\" data-linked=\"State Street down more than 3% despite earnings beat\" data-tweet=\"$STT - State Street down more than 3% despite earnings beat https://seekingalpha.com/news/3302959-state-street-down-3-despite-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3302959-state-street-down-3-despite-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302953\" data-ts=\"1508770258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCS\" target=\"_blank\">ONCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302953-oncosec-medical-inks-7m-direct-capital-raise-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoSec Medical inks $7M direct capital raise; shares down 11%</a></h4><ul><li>OncoSec Medical (<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='red'>-11.3%</font>) slips on triple normal volume in response to its <a href=\"https://seekingalpha.com/pr/16976042-oncosec-announces-7_1-million-registered-direct-offering-priced-market\" target=\"_blank\">agreement </a>with accredited investors to sell 5,270,934 shares of common stock at $1.34375 per share plus 5 1/2-year warrants to purchase up to 3,953,200 shares of common at $1.25. The offering should close by October 25.</li><li>Net proceeds of ~$6.2M will fund working capital and general corporate purposes.</li><li>Friday's close was $1.251.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302953\" data-linked=\"OncoSec Medical inks $7M direct capital raise; shares down 11%\" data-tweet=\"$ONCS - OncoSec Medical inks $7M direct capital raise; shares down 11% https://seekingalpha.com/news/3302953-oncosec-medical-inks-7m-direct-capital-raise-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3302953-oncosec-medical-inks-7m-direct-capital-raise-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302948\" data-ts=\"1508768934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEM\" target=\"_blank\">SEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302948-select-medical-and-dignity-health-to-combine-occupational-medicine-and-urgent-care-businesses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Medical and Dignity Health to combine occupational medicine and urgent care businesses; shares up 4%</a></h4><ul><li>Select Medical Holdings (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='green'>+3.8%</font>) and Dignity Health Holdings have agreed to <a href=\"https://seekingalpha.com/pr/16975772-select-medical-dignity-health-announce-signing-definitive-agreement-combine-concentra-u-s\" target=\"_blank\">combine </a>their occupational medicine and urgent care services businesses, Concentra Group Holdings, LLC and U.S. Healthworks, respectively.</li><li>The transaction, which values U.S. Healthworks at $753M, will be an equity purchase and contribution agreement under which Concentra will acquire all the stock of U.S. Healthworks from Dignity, who will own 20% of the combined company. It should close in Q1 2018.</li><li>U.S. Healthworks operates ~250 medical and onsite clinics in 21 states.</li><li>Earlier this year, Select Medical and Dignity formed a JV to build and operate a 60-bed acute inpatient rehabilitation hospital in the Las Vegas, NV area. The deal also includes joint operation of 12 outpatient rehab clinics there.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302948\" data-linked=\"Select Medical and Dignity Health to combine occupational medicine and urgent care businesses; shares up 4%\" data-tweet=\"$SEM - Select Medical and Dignity Health to combine occupational medicine and urgent care businesses; shares up 4% https://seekingalpha.com/news/3302948-select-medical-and-dignity-health-to-combine-occupational-medicine-and-urgent-care-businesses?source=tweet\" data-url=\"https://seekingalpha.com/news/3302948-select-medical-and-dignity-health-to-combine-occupational-medicine-and-urgent-care-businesses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302946\" data-ts=\"1508768190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302946-linn-energy-to-sell-williston-basin-properties-for-285m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy to sell Williston Basin properties for $285M</a></h4><ul>     <li>Linn Energy (LNGG <font color='green'>+2.5%</font>) is higher after <a href=\"https://seekingalpha.com/pr/16975571-linn-energy-announces-sale-williston-properties-285-million\" target=\"_blank\">agreeing to sell</a> its interest in Williston Basin properties to an undisclosed buyer for $285M.</li>     <li>The properties to be sold consist of ~20K net acres in North Dakota, South Dakota and Montana with ~8K boe/day of Q2 quarter net production.</li>     <li>Linn has been steadily selling off assets, including a $200M sale of Wyoming properties <a href=\"https://seekingalpha.com/news/3299299-linn-energy-sell-wyoming-properties-200m-ups-share-buyback\" target=\"_blank\">earlier this month</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302946\" data-linked=\"Linn Energy to sell Williston Basin properties for $285M\" data-tweet=\"$ROAN - Linn Energy to sell Williston Basin properties for $285M https://seekingalpha.com/news/3302946-linn-energy-to-sell-williston-basin-properties-for-285m?source=tweet\" data-url=\"https://seekingalpha.com/news/3302946-linn-energy-to-sell-williston-basin-properties-for-285m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302945\" data-ts=\"1508768067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302945-this-fifth-straight-decline-for-fang\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">What&#39;s this? Fifth straight decline for FANG</a></h4><ul><li>Normally this wouldn't be worth a mention, but given the one-way direction of the names this year, it'll make for a minor headline.</li><li>FANG (Facebook, Amazon, Netflix, Google) is lower for a fifth consecutive session, with a top-to-bottom&nbsp;<font color='red'>drawdown nearing 3%</font>&nbsp;over that period.</li><li>The Nasdaq early today is&nbsp;<font color='red'>lower by 0.2%</font>, while the S&amp;P 500 is flat.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302945\" data-linked=\"What&#39;s this? Fifth straight decline for FANG\" data-tweet=\"What&#39;s this? Fifth straight decline for FANG https://seekingalpha.com/news/3302945-this-fifth-straight-decline-for-fang?source=tweet\" data-url=\"https://seekingalpha.com/news/3302945-this-fifth-straight-decline-for-fang\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302943\" data-ts=\"1508767845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302943-t-mobileplus-2-profits-beat-carrier-boosts-2017-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile +2% as profits beat, carrier boosts 2017 guidance</a></h4><ul>    <li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) is <font color='green'>up 2%</font> after posting <a href=\"https://seekingalpha.com/news/3302848-t-mobile-us-beats-0_17-revenue-line\" target=\"_blank\">Q3 earnings</a> that beat profit expectations and featured another boost to full-year guidance.</li>    <li>Net income rose 50% Y/Y to $550M; hurricane losses in Texas, Florida, and Puerto Rico had a negative impact of $90M, though assessment is still going on for Q4.</li>    <li>It's raising and narrowing guidance on branded postpaid net adds to 3.3M-3.6M, from 3M-3.6M. It's also boosting its adjusted EBITDA target again, to $10.8B-$11B from $10.5B-$10.9B (vs. consensus for $10.9B).</li>    <li>Revenues rose 7.6% to $10.02B, and service revenues were up 7% to $7.63B.</li>    <li>It's expecting to lead the industry's customer growth again, posting net additions of 1.3M (its 18th straight quarter of 1M-plus); 595,000 branded postpaid phone net additions, part of 817,000 branded postpaid net additions. Postpaid phone churn fell 9 basis points to 1.23%.</li>    <li>Prepaid net adds came to 226,000.</li>    <li>Branded postpaid phone ARPU came to $46.93, down 2.5%; branded prepaid ARPU was up 2.4% to a record-high $38.93.</li>    <li><a href=\"https://newsroom.t-mobile.com/video_display.cfm?video_id=15925\" target=\"_blank\">CEO John Legere's earnings video blog</a></li>    <li><a href=\"https://seekingalpha.com/pr/16975679-t-mobile-delivers-record-financial-results-q3-2017-raises-guidance-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302943\" data-linked=\"T-Mobile +2% as profits beat, carrier boosts 2017 guidance\" data-tweet=\"$TMUS - T-Mobile +2% as profits beat, carrier boosts 2017 guidance https://seekingalpha.com/news/3302943-t-mobileplus-2-profits-beat-carrier-boosts-2017-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3302943-t-mobileplus-2-profits-beat-carrier-boosts-2017-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302936\" data-ts=\"1508766602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302936-investors-watch-shanghai-for-decision-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors watch Shanghai for decision on Tesla</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) could face some <a href=\"https://www.wsj.com/articles/teslas-china-reach-may-exceed-its-grasp-1508762663\" target=\"_blank\">hurdles</a> with its strategy in China to become the first foreign automaker to build a wholly owned plant in order to \"safeguard\" its technology and retain 100% of profits, reports The Wall Street Journal.</li> <li>A huge wildcard with the ambitious plan is how the Shanghai government will treat tariffs for Tesla cars produced in the free-trade zone. There hasn't been any official notification from Shanghai yet on the WSJ report.</li> <li>China is Tesla's second biggest market for revenue.</li> <li>Shares of Tesla are <font color='green'>up 0.76%</font> in early Monday morning trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302777-tesla-build-factory-china\" target=\"_blank\">Tesla to build factory in China</a> (Oct. 22)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302936\" data-linked=\"Investors watch Shanghai for decision on Tesla\" data-tweet=\"$TSLA - Investors watch Shanghai for decision on Tesla https://seekingalpha.com/news/3302936-investors-watch-shanghai-for-decision-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3302936-investors-watch-shanghai-for-decision-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302930\" data-ts=\"1508765683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302930-alimera-registers-100m-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alimera registers $100M mixed shelf offering</a></h4><ul><li>Alimera Sciences (<a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a>) files an <a href=\"https://www.sec.gov/Archives/edgar/data/1267602/000126760217000065/alims-3.htm\" target=\"_blank\">S-3</a> for a $100M mixed shelf offering. Net proceeds will be used for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302930\" data-linked=\"Alimera registers $100M mixed shelf offering\" data-tweet=\"$ALIM - Alimera registers $100M mixed shelf offering https://seekingalpha.com/news/3302930-alimera-registers-100m-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3302930-alimera-registers-100m-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302925\" data-ts=\"1508765473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302925-citi-research-reiterates-sell-rating-for-amd-on-intel-competition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi Research reiterates Sell rating for AMD on Intel competition</a></h4><ul><li>Citi Research <a href=\"https://www.cnbc.com/2017/10/23/citi-amd-to-plunge-more-than-60-percent-because-of-intels-new-chips.html\" target=\"_blank\">reiterates</a> its Sell rating for Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) and a $5 price target.</li><li>Analyst Christopher Danely writes that Intel&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) new CPUs &ldquo;appear to have extended its performance lead&rdquo; and sees AMD&rsquo;s CPU market share worsening over time as competition increases.</li><li>The analyst forecasts a 7.2% market share for AMD in Q3.</li><li>Danely cites benchmark reports showing Intel&rsquo;s new chips outperforming AMD&rsquo;s Ryzen processors by 20%.</li><li>AMD will report Q3 results on October 24.</li><li>AMD shares are&nbsp;<font color='green'>up 0.87%</font>&nbsp;premarket to $13.93.</li><li><strong>Correction:</strong> Removed math error that went with a previous version of the article.</li><li>AMD shares are currently&nbsp;<font color='green'>up 1.81%</font>&nbsp;to $14.06.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302925\" data-linked=\"Citi Research reiterates Sell rating for AMD on Intel competition\" data-tweet=\"$AMD $AMD $INTC - Citi Research reiterates Sell rating for AMD on Intel competition https://seekingalpha.com/news/3302925-citi-research-reiterates-sell-rating-for-amd-on-intel-competition?source=tweet\" data-url=\"https://seekingalpha.com/news/3302925-citi-research-reiterates-sell-rating-for-amd-on-intel-competition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302922\" data-ts=\"1508765147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302922-premarket-gainers-of-9-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:15 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a>&nbsp;<font color='green'>+35%</font>&nbsp;on DBV Tech's Viaskin Peanut <a href=\"https://seekingalpha.com/news/3302886-aimmune-46-percent-premarket-dbv-techs-viaskin-peanut-flop\" target=\"_blank\">flop</a>.</li><li><a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a> <font color='green'>+25%</font>.</li><li><a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a>&nbsp;<font color='green'>+19%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3302870-petmed-express-beats-0_13-beats-revenue\" target=\"_blank\">earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/KTCC' title='Key Tronic Corporation'>KTCC</a>&nbsp;<font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3302902-revised-exchange-offer-key-tronic\" target=\"_blank\">announcing</a> revised exchange offer for Key Tronic.</li><li><a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a>&nbsp;<font color='green'>+13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3302908-agenus-creates-cell-therapy-focused-subsidiary-shares-12-percent-premarket\" target=\"_blank\">creating</a> cell therapy-focused subsidiary.</li><li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>&nbsp;<font color='green'>+13%.</font></li><li>EVOK&nbsp;<font color='green'>+11%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3302895-evoke-submit-u-s-marketing-application-gimoti-q1-shares-ahead-14-percent-preamarket\" target=\"_blank\">announcing</a>&nbsp;positive topline Results from comparative exposure Pharmacokinetic study for Gimoti.</li><li><a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>&nbsp;<font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3302868-seagate-technology-beats-0_11-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>&nbsp;<font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3302858-pluristem-receives-european-patent-covering-plx-r18-chemotherapy-ars-genetic-disorders\" target=\"_blank\">receiving</a> European patent covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases.</li><li><a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3302922\" data-linked=\"Premarket Gainers as of 9:15 am\" data-tweet=\"$AIMT $SSC-OLD $PETS - Premarket Gainers as of 9:15 am https://seekingalpha.com/news/3302922-premarket-gainers-of-9-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3302922-premarket-gainers-of-9-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302921\" data-ts=\"1508765131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYO\" target=\"_blank\">MYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302921-myomo-registers-6m-stock-and-warrant-offering-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myomo registers $6M stock and warrant offering; shares down 10% premarket</a></h4><ul><li>Myomo (NYSEMKT:<a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a>) slips&nbsp;<font color='red'>10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1369290/000121390017010801/fs12017_myomoinc.htm\" target=\"_blank\">S-1</a> filing for a $6M public offering of common stock and five-year warrants, issued separately.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302921\" data-linked=\"Myomo registers $6M stock and warrant offering; shares down 10% premarket\" data-tweet=\"$MYO - Myomo registers $6M stock and warrant offering; shares down 10% premarket https://seekingalpha.com/news/3302921-myomo-registers-6m-stock-and-warrant-offering-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302921-myomo-registers-6m-stock-and-warrant-offering-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302915\" data-ts=\"1508764690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SN\" target=\"_blank\">SN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302915-sanchez-energy-says-q3-production-jumps-43\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanchez Energy says Q3 production jumps 43%</a></h4><ul>     <li>Sanchez Energy (NYSE:<a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a>) <font color='green'>+2.2%</font> premarket after reporting <a href=\"https://seekingalpha.com/pr/16975535-sanchez-energy-announces-third-quarter-2017-operating-results-43-percent-annual-growth-drives\" target=\"_blank\">Q3 production jumped 43% Y/Y</a> to ~6.8M boe, or 73,783 boe/day, which is at the high end of the company's guidance despite severe flooding from Hurricane Harvey.</li><li>SN says it brought 41 wells online in the Comanche area during Q3, with an  additional 103 Comanche wells currently undergoing or awaiting  completion.</li>     <li>The company also says it is currently producing at a record rate in excess of 80K boe/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302915\" data-linked=\"Sanchez Energy says Q3 production jumps 43%\" data-tweet=\"$SN $SNEC - Sanchez Energy says Q3 production jumps 43% https://seekingalpha.com/news/3302915-sanchez-energy-says-q3-production-jumps-43?source=tweet\" data-url=\"https://seekingalpha.com/news/3302915-sanchez-energy-says-q3-production-jumps-43\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302913\" data-ts=\"1508764480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302913-ubs-sees-j-b-hunt-transport-trucking-to-new-highs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS sees J.B. Hunt Transport trucking to new highs</a></h4><ul> <li>UBS takes its rating on J.B. Hunt Transport Services (NASDAQ:<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a>) to Buy from Neutral.</li> <li>The investment firm's price target of $126 reps 18% upside potential and is well above the all-time high for JBHT of $111.98.</li><li>Marketplace author James Sands (<a href=\"https://seekingalpha.com/author/james-sands/research\" target=\"_blank\">Transports In Focus</a>)&nbsp;issued <a href=\"https://seekingalpha.com/article/4113613-j-b-hunt-results-weigh-trucking-industry-trucking-may-soon-push-higher\" target=\"_blank\">positive comments</a> on J.B. Hunt last week in his post-earnings breakdown.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3302913\" data-linked=\"UBS sees J.B. Hunt Transport trucking to new highs\" data-tweet=\"$JBHT - UBS sees J.B. Hunt Transport trucking to new highs https://seekingalpha.com/news/3302913-ubs-sees-j-b-hunt-transport-trucking-to-new-highs?source=tweet\" data-url=\"https://seekingalpha.com/news/3302913-ubs-sees-j-b-hunt-transport-trucking-to-new-highs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302912\" data-ts=\"1508764476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302912-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a>&nbsp;<font color='red'>-49%</font>&nbsp;on Viaskin Peanut <a href=\"https://seekingalpha.com/news/3302886-aimmune-46-percent-premarket-dbv-techs-viaskin-peanut-flop\" target=\"_blank\">flop</a>.</li><li><a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='red'>-15%</font>.</li><li><a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16975568-eldorado-gold-provides-update-kisladag-operations\" target=\"_blank\">providing</a> an update on Kisladag operations.</li><li><a href='https://seekingalpha.com/symbol/ATR' title='AptarGroup Inc.'>ATR</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3302818-premarket-analyst-action-healthcare\" target=\"_blank\">lower</a> analyst rating.</li><li><a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>&nbsp;<font color='red'>-9%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3302850-global-blood-drops-development-gbt440-ipf-due-lack-sufficient-treatment-benefit-shares-12\" target=\"_blank\">announcing</a> discontinuation of IPF Program</li><li><a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a> <font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16976042-oncosec-announces-7_1-million-registered-direct-offering-priced-market\" target=\"_blank\">announcing</a> $7.1M registered direct offering.</li><li><a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='red'>-5%</font>.</li><li>ADHD <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3302912\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$DBVT $SHIP $EGO - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3302912-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3302912-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302908\" data-ts=\"1508763721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGEN\" target=\"_blank\">AGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302908-agenus-creates-cell-therapy-focused-subsidiary-shares-up-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agenus creates cell therapy-focused subsidiary; shares up 12% premarket</a></h4><ul><li>Agenus (NASDAQ:<a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a>) <a href=\"https://seekingalpha.com/pr/16975818-agenus-creates-new-cell-therapy-subsidiary-named-agentus-therapeutics\" target=\"_blank\">launches</a> a subsidiary, AgenTus Therapeutics, that will focus on developing and commercializing cell therapies. Specifically, it will advance adoptive cell therapy formats aimed at enabling off-the-shelf living drugs.</li><li>Living drugs are immune cells taken from the patients, reengineered, then reinfused back into the body to boost the immune system to fight cancer.</li><li>Current pipeline assets include monotherapies and components of combination treatments in both solid tumors and blood cancers.</li><li>Bruno Lucidi will lead the organization.</li><li>Shares are up&nbsp;<font color='green'>12%</font>&nbsp;premarket on the FDA approval of Glaxo's shingles vaccine which uses Agenus' Stimulon adjuvant.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302908\" data-linked=\"Agenus creates cell therapy-focused subsidiary; shares up 12% premarket\" data-tweet=\"$AGEN - Agenus creates cell therapy-focused subsidiary; shares up 12% premarket https://seekingalpha.com/news/3302908-agenus-creates-cell-therapy-focused-subsidiary-shares-up-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302908-agenus-creates-cell-therapy-focused-subsidiary-shares-up-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302903\" data-ts=\"1508763178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302903-rio-tinto-downgraded-rbc-on-exposure-to-commodity-volatility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto downgraded by RBC on exposure to commodity volatility</a></h4><ul>     <li>Rio Tinto (NYSE:<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a>)&nbsp;<font color='red'>-1.5%</font> premarket after RBC&nbsp;Capital <a href=\"http://www.barrons.com/articles/rio-tinto-downgraded-by-rbc-1508740969\" target=\"_blank\">downgrades</a> shares to Sector Perform from Market Perform, saying the company's strong balance sheet and high quality growth projects already are factored into the stock price.</li>     <li>RBC thinks Rio is well placed to benefit from structural reforms in the Chinese steel and aluminum sectors but expects&nbsp;volatility in commodity markets as Chinese growth slows in Q4.</li>     <li>The firm still prefers Rio to rival BHP&nbsp;Billiotn (NYSE:<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a>), believing Rio continues to provide a clearer strategy than BHP, with high-quality growth options including Amrun and Oyu Tolgoi progressing on schedule.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302903\" data-linked=\"Rio Tinto downgraded by RBC on exposure to commodity volatility\" data-tweet=\"$RIO $RIO $BHP - Rio Tinto downgraded by RBC on exposure to commodity volatility https://seekingalpha.com/news/3302903-rio-tinto-downgraded-rbc-on-exposure-to-commodity-volatility?source=tweet\" data-url=\"https://seekingalpha.com/news/3302903-rio-tinto-downgraded-rbc-on-exposure-to-commodity-volatility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302901\" data-ts=\"1508763109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302901-agenus-up-11-premarket-on-fda-ok-of-glaxos-shingles-vaccine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agenus up 11% premarket on FDA OK of Glaxo&#39;s shingles vaccine</a></h4><ul><li>As expected, the FDA has <a href=\"https://seekingalpha.com/pr/16975364-fda-approves-gsks-shingles-vaccine-agenus-qsminus-21-stimulon-adjuvant\" target=\"_blank\">approved </a>GlaxoSmithKline's (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a>) Shingrix [Zoster Vaccine (Adjuvanted)] shingles vaccine. In September, an FDA advisory committee voted 11 - 0 backing approval.</li><li>Agenus (NASDAQ:<a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a>), the developer of the QS-21 adjuvant Stimulon used in Shingrix, is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on robust volume.</li><li>Glaxo is down&nbsp;<font color='red'>0.5%</font>&nbsp;premarket on robust volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3277776-agenus-breaks-brief-consolidation-glaxo-shingles-vaccine-data-stoked-move-shares-ahead-9\" target=\"_blank\">Agenus breaks out of brief consolidation after Glaxo shingles vaccine data-stoked up move; shares ahead 9%</a> (July 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302901\" data-linked=\"Agenus up 11% premarket on FDA OK of Glaxo&#39;s shingles vaccine\" data-tweet=\"$GSK $GSK $AGEN - Agenus up 11% premarket on FDA OK of Glaxo&#39;s shingles vaccine https://seekingalpha.com/news/3302901-agenus-up-11-premarket-on-fda-ok-of-glaxos-shingles-vaccine?source=tweet\" data-url=\"https://seekingalpha.com/news/3302901-agenus-up-11-premarket-on-fda-ok-of-glaxos-shingles-vaccine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302895\" data-ts=\"1508762603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOK\" target=\"_blank\">EVOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302895-evoke-to-submit-u-s-marketing-application-for-gimoti-in-q1-shares-ahead-14-preamarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evoke to submit U.S. marketing application for Gimoti in Q1; shares ahead 14% preamarket</a></h4><ul><li>Evoke Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a>) is up&nbsp;<font color='green'>14%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16975675-evoke-pharma-announces-positive-topline-results-comparative-exposure-pharmacokinetic-study\" target=\"_blank\">announcement </a>that it intends to file a 505(b)(2) New Drug Application next quarter seeking approval for Gimoti (metoclopramide) for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. The company just completed one of remaining hurdles with positive results from a comparative exposure pharmacokinetic study that showed nasally delivered Gimoti had similar systemic exposure to the reference drug, Reglan Tablets.</li><li>Two of the three tested doses of Gimoti met the selection criteria. The maximum observed plasma concentration of Gimoti was slightly lower than the bioequivalence range of 80 - 125% of Reglan, however.</li><li>A 505(b)(2) application is an abbreviated approval pathway that includes data generated by others.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302895\" data-linked=\"Evoke to submit U.S. marketing application for Gimoti in Q1; shares ahead 14% preamarket\" data-tweet=\"$EVOK - Evoke to submit U.S. marketing application for Gimoti in Q1; shares ahead 14% preamarket https://seekingalpha.com/news/3302895-evoke-to-submit-u-s-marketing-application-for-gimoti-in-q1-shares-ahead-14-preamarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302895-evoke-to-submit-u-s-marketing-application-for-gimoti-in-q1-shares-ahead-14-preamarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302899\" data-ts=\"1508762318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTOR\" target=\"_blank\">MTOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302899-meritor-sets-up-distribution-center-for-west-coast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meritor  sets up distribution center for West Coast</a></h4><ul>          <li>Meritor (<a href='https://seekingalpha.com/symbol/MTOR' title='Meritor, Inc.'>MTOR</a>)&nbsp;announces the opening of its West Coast Aftermarket Distribution Center in Santa Fe Springs, California to fulfill aftermarket orders from warehouse distributors and dealers in 13 states.</li>     <li>The company says the facility will stock the complete Meritor Aftermarket brand portfolio for customers in Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.</li>     <li>MTOR  <font color='green'>+1.21%</font> premarket to  $26.80.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16975870-meritor-announces-new-west-coast-aftermarket-distribution-center\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302899\" data-linked=\"Meritor  sets up distribution center for West Coast\" data-tweet=\"$MTOR - Meritor sets up distribution center for West Coast https://seekingalpha.com/news/3302899-meritor-sets-up-distribution-center-for-west-coast?source=tweet\" data-url=\"https://seekingalpha.com/news/3302899-meritor-sets-up-distribution-center-for-west-coast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302889\" data-ts=\"1508761715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302889-cisco-will-acquire-broadsoft-for-1_9b-in-cash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco will acquire BroadSoft for $1.9B in cash</a></h4><ul><li>        Cisco (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) <a href=\"https://seekingalpha.com/pr/16975703-cisco-announces-agreement-acquire-broadsoft-leader-cloud-calling-contact-center-solutions\" target=\"_blank\">announces</a> a definitive agreement to acquire BroadSoft (BSFT) for $55 per share or about $1.9B in cash. &nbsp;</li><li>           Cisco expects the acquisition to close during 1Q18. </li><li>           After the deal closes, BroadSoft employees will join Cisco&rsquo;s Unified Communications Technology Group. &nbsp; </li><li>        Cisco shares are&nbsp;<font color='green'>up 0.53%</font>&nbsp;premarket.</li><li>               BroadSoft shares are&nbsp;<font color='green'>up 16.88%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302790-reports-cisco-close-possible-2b-deal-broadsoft\" target=\"_blank\">Reports: Cisco close to possible $2B deal for BroadSoft</a> (Oct. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302889\" data-linked=\"Cisco will acquire BroadSoft for $1.9B in cash\" data-tweet=\"$CSCO - Cisco will acquire BroadSoft for $1.9B in cash https://seekingalpha.com/news/3302889-cisco-will-acquire-broadsoft-for-1_9b-in-cash?source=tweet\" data-url=\"https://seekingalpha.com/news/3302889-cisco-will-acquire-broadsoft-for-1_9b-in-cash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302888\" data-ts=\"1508761565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302888-mattel-falls-after-soft-hasbro-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel falls after soft Hasbro guidance</a></h4><ul> <li>Shares of Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) are <font color='red'>down a clean 2%</font> in premarket trading after rival Hasbro issues soft Q4 revenue guidance.</li> <li>Beyond the pressure in the U.S. toy market, Hasbro pointed to weakness in the U.K. and Brazil.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3302812-hasbro-beats-0_11-beats-revenue\" target=\"_blank\">Hasbro beats by $0.11, beats on revenue</a> (Oct. 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302815-hasbro-earnings-beat\" target=\"_blank\">Hasbro up on earnings beat</a> (Oct. 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302888\" data-linked=\"Mattel falls after soft Hasbro guidance\" data-tweet=\"$MAT - Mattel falls after soft Hasbro guidance https://seekingalpha.com/news/3302888-mattel-falls-after-soft-hasbro-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3302888-mattel-falls-after-soft-hasbro-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}